Emerging technologies and innovation policies in India: how disparities in cancer research might be furthering health inequities?

Inequity in health research is understood as a major impediment to development.The paper uses empirical analysis performed on a unique data set of publications and clinical trials related to cancer research to explore the public policy dimensions of health care research in India. It traces disparities that result from predilections in science technology and innovation policies in India. The paper analyses disparity in health research using emerging technologies and its implications for equity in health research. The paper argues that the use of emerging technologies in cancer research has shifted research focus from cancers affecting poor population in India.Abbreviations AA – Age Adjusted Incidence Rates; CTRI – Clinical Trail Registry of India; DBT – Department of Biotechnology; DST – Department of Science and Technology; ICMR – Indian Council for Medical Research; Mabs – Monoclonal antibodies; NBDS – National Biotechnology Development Strategy; NCI – National Cancer Institute; NSTI – Nanoscience and Technology Initiative; SCI – Science Citation Index; TB – Tuberculosis; WOS – Web of Science.